RDF/XML JSON-LD N3/Turtle RDF/JSON
Author profile at the institutional portal

Colomer Bosch, Ramon ramon.colomer@uam.es

Medicina / Universidad Autónoma de Madrid

Publications

Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever - A prospective, randomized clinical trial

  • Manuel Hidalgo
  • Javier Hornedo
  • Carlos Lumbreras
  • José M Trigo
  • Ramón Colomer
  • Sofía Perea
  • Carlos Gómez
  • Ana Ruiz
  • Rocio García?Carbonero
  • Hernán Cortés?Funes
... View more Collapse

Cancer (p. 213-219) - 1/1/1999

10.1002/(sici)1097-0142(19990101)85:1<213::aid-cncr29>3.3.co;2-4 View at source

  • ISSN 0008543X

Overexpression and hyperactivity of breast cancer- associated fatty acid synthase (oncogenic antigen-519) is insensitive to normal arachidonic fatty acid-induced suppression in lipogenic tissues but it is selectively inhibited by tumoricidal alpha-linolenic and gamma-linolenic fatty acids: A novel mechanism by which dietary fat can alter mammary tumorigenesis

  • Menendez, J.A.
  • Ropero, S.
  • Mehmi, I.
  • Atlas, E.
  • Colomer, R.
  • Lupu, R.

International Journal Of Oncology (p. 1369-1383) - 1/1/2004

  • ISSN 10196439
  • ISSN/ISBN 1019-6439

Overexpression of fatty acid synthase gene activates HER1/HER2 tyrosine kinase receptors in human breast epithelial cells

  • Vazquez-Martin, A.
  • Colomer, R.
  • Brunet, J.
  • Lupu, R.
  • Menendez, J. A.;

Cell Proliferation (p. 59-85) - 1/2/2008

10.1111/j.1365-2184.2007.00498.x

  • ISSN 09607722
  • iMarina

P198 Prospective trans-GEICAM study of the impact of the 21-gene recurrence score assay and traditional clinico-pathological factors on clinical decision making in women with …

  • J Albanell
  • R Colomer
  • M Ruiz-Borrego
  • E Alba
  • JA García Saenz
  • M Martin
  • I Tusquets
  • F Rojo
  • I Faull
  • A Lluch
... View more Collapse

The Breast (p. S43-S43) - 1/1/2011

  • iMarina

Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trial.

  • Colomer, R
  • Llombart, A
  • Lluch, A
  • Ojeda, B
  • Barnadas, A
  • Caranana, V
  • Fernandez, Y
  • De Paz, L
  • Guillem, V
  • Alonso, S;
... View more Collapse

Seminars In Oncology (p. 20-24) - 4/3/2000

  • ISSN 00937754
  • iMarina

Patient selection in high-dose chemotherapy trials: Relevance in high-risk breast cancer

  • GarciaCarbonero, R
  • Hidalgo, M
  • PazAres, L
  • Calzas, J
  • Gomez, H
  • Guerra, JA
  • Hitt, R
  • Hornedo, J
  • Colomer, R
  • CortesFunes, H;
... View more Collapse

Journal Of Clinical Oncology (p. 3178-3184) - 1/1/1997

10.1200/jco.1997.15.10.3178 View at source

  • ISSN 0732183X

Peripheral Blood Mononuclear Cells Predict Therapeutic Efficacy of Immunotherapy in NSCLC

  • Rogado, J.
  • Pozo, F.
  • Troule, K.
  • Sánchez-Torres, J.M.
  • Romero-Laorden, N.
  • Mondejar, R.
  • Donnay, O.
  • Ballesteros, A.
  • Pacheco-Barcia, V.
  • Aspa, J.
  • Al-Shahrour, F.
  • Alfranca, A.
  • Colomer, R.
... View more Collapse

Cancers - 1/6/2022

Editor: MDPI

10.3390/cancers14122898 View at source

  • ISSN 20726694
  • ISSN/ISBN 2072-6694

Pertuzumab, trastuzumab, and standard anthracycline- and taxane-based chemotherapy for the neoadjuvant treatment of patients with HER2-positive localized breast cancer (BERENICE): a phase II, open-label, multicenter, multinational cardiac safety study

  • Swain, S. M.
  • Ewer, M. S.
  • Viale, G.
  • Delaloge, S.
  • Ferrero, J-M
  • Verrill, M.
  • Colomer, R.
  • Vieira, C.
  • Werner, T. L.
  • Douthwaite, H.
  • Bradley, D.
  • Waldron-Lynch, M.
  • Kiermaier, A.
  • Eng-Wong, J.
  • Dang, C.;BERENICE Study Grp
... View more Collapse

Annals Of Oncology (p. 646-653) - 1/3/2018

10.1093/annonc/mdx773 View at source

  • ISSN 09237534

Pharmacological and small interference RNA-mediated inhibition of breast cancer-associated fatty acid synthase (oncogenic antigen-519) synergistically enhances Taxol (Paclitaxel)-induced cytotoxicity

  • Menendez, JA
  • Vellon, L
  • Colomer, R
  • Lupu, R;

International Journal Of Cancer (p. 19-35) - 20/5/2005

10.1002/ijc.20754 View at source

  • ISSN 00207136

Pharmacological and small interference RNA?mediated inhibition of breast cancer?associated fatty acid synthase (oncogenic antigen?519) synergistically enhances Taxol …

  • Javier A Menendez
  • Luciano Vellon
  • Ramon Colomer
  • Ruth Lupu

International Journal Of Cancer (p. 19-35) - 1/1/2005

  • ISSN 00207136
  • iMarina

Adding pertuzumab in neoadjuvant treatment of patients with HER2 (+) breast cancer in Spain: A cost offsets study

  • J Albanell
  • E Ciruelos
  • R Colomer
  • J De la Haba
  • M Martin
  • De Salas-Cansado
  • B Munoz-Molina
  • C Tournier
  • P Thuresson
  • W Schleich
... View more Collapse

1/1/2015

  • iMarina

Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  • J Rogado
  • MD Fenor De La Maza
  • V Pacheco-Barcia
  • JM Serra
  • P Toquero
  • B Vera
  • A Ballesteros
  • R Mondejar
  • O Donnay
  • B Obispo
  • R Colomer
  • JM Sanchez-Torres
... View more Collapse

1/1/2017

  • iMarina

Safety of adjuvant treatment with pertuzumab plus trastuzumab after neoadjuvant anthracycline-based chemotherapy in patients with HER2-positive localized breast cancer: Updated …

  • Chau Dang
  • Michael S Ewer
  • Suzette Delaloge
  • Jean-Marc Ferrero
  • Mark Verrill
  • Ramon Colomer
  • Claudia Vieira
  • Luis de la Cruz Merino
  • Jennifer Lucas
  • Theresa L Werner
  • Hannah Douthwaite
  • Denise Bradley
  • Maeve Waldron-Lynch
  • Jennifer Eng-Wong
  • Sandra M Swain
... View more Collapse

1/1/2018

  • iMarina

Tratado de oncología

  • Hernán Cortés-Funes
  • Ramón Colomer Bosch
  • Emilio Alba Conejo

1/1/2009

  • ISBN 9788492620166
  • iMarina

Fatty acid metabolism in cancer cell survival: A new anti-cancer target

  • Porta, Rut
  • Colomer, Ramon
  • Puig, Teresa;

Cell Respiration And Cell Survival: Processes, Types And Effects (p. 193-208) - 1/12/2011

  • iMarina

Medicina de precisión en oncología: Éxitos y perspectivas bioéticas

  • Ramón Colomer Bosch

Bioética Y Cáncer (p. 17-26) - 1/1/2020

  • iMarina

Tratamiento hormonal del cáncer

  • Ramón Colomer Bosch
  • M L Amador
  • J González Cortijo
  • MV Tornamira

Oncología En Atención Primaria / Coord. Por Vicente Valentín Maganto - 1/1/2003

  • iMarina

18F-misonidazole PET (FMISO-PET) monitors vascular normalization (VN) and predicts benefit from antiangiogenic treatment plus chemotherapy in pancreas cancer

  • Mondejar, Tamara
  • Hernadez-Agudo, Elena
  • Soto-Montenegro, Marisa
  • Megias, Diego
  • Cebrian, David
  • Sanchez, Jesus
  • Mulero, Francisca
  • Colomer, Ramon
  • Hidalgo, Manuel
  • Desco, Manuel
  • Quintela-Fandino, Miguel;
... View more Collapse

Cancer Research - 1/1/2015

10.1158/1538-7445.am2015-1493 View at source

  • ISSN 00085472

A decade of clinical investigation in elderly patients with non-Hodgkin's lymphoma: Results as reported in the literature

  • Gomez, H
  • Colomer, R
  • Casttellanos, D
  • CortesFunes, H;

European Journal Of Cancer (p. 1205-1205) - 1/1/1997

  • ISSN 09598049
  • iMarina

ADDING PERTUZUMAB IN NEOADJUVANT TREATMENT OF PATIENTS WITH HER2(+) BREAST CANCER IN SPAIN: A COST OFFSETS STUDY

  • Albanell, J.
  • Ciruelos, E.
  • Colomer, R.
  • De la Haba, J.
  • Martin, M.
  • De Salas-Cansado, M.
  • Munoz-Molina, B.
  • Tournier, C.
  • Thuresson, P.
  • Schleich, W.;MORSE Hlth Technology Assessment
  • Global Pricing Market Access
... View more Collapse

Basic & Clinical Pharmacology & Toxicology (p. 42-42) - 1/1/2015

  • ISSN 17427835
  • iMarina

An accelerated loading regimen for trastuzumab leads to early higher than steady-state serum concentrations

  • B Leyland-Jones
  • R Colomer
  • M Trudeau
  • A Wardley
  • J Latreille
  • D Cameron
  • R Cubedo
  • N Al-Sakaff
  • JE Charoin
  • J Cortés
... View more Collapse

European Journal Of Cancer, Supplement (p. 215-215) - 1/1/2007

10.1016/s1359-6349(07)70867-4 View at source

  • ISSN 13596349

Are Inflammatory Markers Predictive of Nivolumab Efficacy in Advanced Non-Small-Cell Lung Cancer (NSCLC)?

  • J Rogado
  • Fenor De La Maza
  • V Pacheco-Barcia
  • J Serra
  • P Toquero
  • B Vera
  • A Ballesteros
  • R Mondéjar
  • O Donnay
  • B Obispo
  • R Colomer
  • J Sánchez-Torres
... View more Collapse

Journal Of Thoracic Oncology (p. S2107-S2108) - 1/1/2017

  • ISSN 15560864
  • iMarina

Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)

  • Rogado Revuelta, Jacobo
  • Romero-Laorden, Nuria
  • Sanchez Torres, Jose Miguel
  • Pacheco-Barcia, Vilma
  • Ballesteros, Anabel
  • Maria Ramos-Levi, Ana
  • Arranz, Reyes
  • Lorenzo, Alicia
  • Gullon, Pedro
  • Garrido Garcia, Ana
  • Maria Serra, Jose
  • Donnay, Olga
  • Adrados, Magdalena
  • Costas, Pablo
  • Aspa, Javier
  • Alfranca, Arantza
  • Fenor De la Maza, Maria Dolores
  • Mondejar, Rebeca
  • Colomer, Ramon;
... View more Collapse

Journal Of Clinical Oncology - 1/1/2019

  • ISSN 0732183X
  • iMarina

Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with metastatic breast cancer receiving chemotherapy

  • Marangolo, M.
  • Lang, I.
  • Beato, C.
  • Colomer, R.
  • Ukarma, L.;

European Journal Of Cancer, Supplement (p. 388-388) - 1/1/2005

  • ISSN 13596349
  • iMarina

Breast cancer-Anaemia and the Value of Erythropoietin (BRAVE): preliminary results from a study of the efficacy of epoetin beta 30,000 IU once weekly in patients with …

  • M Marangolo
  • I Lang
  • C Beato
  • R Colomer
  • L Ukarma

(p. 388-388) - 1/1/2005

  • iMarina

CA 15.3 - A NEW MARKER FOR BREAST-CANCER (BC) PRELIMINARY-RESULTS

  • SOLE, LA
  • COLOMER, R
  • NAVARRO, M
  • ENCABO, G
  • RUIBAL, A;

Anticancer Research (p. 601-602) - 1/1/1985

  • ISSN 02507005
  • iMarina

CONTRIBUTION OF TRASTUZUMAB TO THE PROGNOSTIC IMPROVEMENT OF HER2-POSITIVE EARLY BREAST CANCER IN SPAIN

  • Ciruelos, E.
  • Alba, E.
  • Lopez, R.
  • Lluch, A.
  • Martin, M.
  • Arroyo, I
  • Navarro, B.
  • Carcedo, D.
  • Colomer, R.
  • Albanell, J.;
... View more Collapse

Value In Health (p. S18-S18) - 1/1/2018

10.1016/j.jval.2018.09.102 View at source

  • ISSN 10983015

[Generalized cutaneous-nodal metastatic spread as initial manifestation of the recurrence of a gastric adenocarcinoma]

  • Sanchez-Munoz, A
  • Gravalos Castro, C
  • Colomer Bosch, R
  • Garcia Velasco, A
  • Garcia, J P
  • Cortes-Funes, H

Revista Clinica Espanola (p. 597-598) - 1/1/2003

10.1157/13053731

  • ISSN 15781860
  • iMarina

A phase II study of sequential docetaxel followed by doxorubicin/cyclophosphamide as first-line chemotherapy for metastatic breast cancer

  • Antón A, Hornedo J, Lluch A, Massuti B, Corral M, Colomer R

Clinical Breast Cancer (p. 286-91) - 1/1/2003

10.3816/cbc.2003.n.034 View at source

  • ISSN 15268209

Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE)

  • Johnston SRD, Harbeck N, Hegg R, Toi M, Martin M, Shao ZM, Zhang QY, Martinez Rodriguez JL, Campone M, Hamilton E, Sohn J, Guarneri V, Okada M, Boyle F, Neven P, Cortés J, Huober J, Wardley A, Tolaney SM, Cicin I, Smith IC, Frenzel M, Headley D, Wei R, San Antonio B, Hulstijn M, Cox J, O'Shaughnessy J, Rastogi P, monarchE Committee Members and Investigators

Journal Of Clinical Oncology (p. 3987-3998) - 1/12/2020

10.1200/jco.20.02514

  • ISSN 0732183X
  • iMarina

Phase I/II study of paclitaxel/cisplatin as first-line therapy for locally advanced head and neck cancer.

  • Hitt, R
  • Paz-Ares, L
  • Hidalgo, M
  • Colomer, R
  • Brandariz, A
  • Pena, M
  • Alvarez-Vicent, J
  • Hornedo, J
  • Cortes-Funes, H;
... View more Collapse

Seminars In Oncology (p. S19-20) - 1/12/1997

  • ISSN 00937754
  • iMarina

Role of interferon alfa-2b in the induction and maintenance treatment of low-grade non-Hodgkin's lymphoma: results from a prospective, multicenter trial with double randomization

  • Arranz, R.
  • García-Alfonso, P.
  • Sobrino, P.
  • Zamora, P.
  • Carrión, R.
  • García-Laraña, J.
  • Pérez, G.
  • López, J.
  • Lavilla, E.
  • Lozano, M.
  • Rayón, C.
  • Colomer, R.
  • González Barón, M.
  • Flores, E.
  • Pérez-Manga, G.
  • Fernández-Rañada, J.M.
... View more Collapse

Journal Of Clinical Oncology (p. 1538-1546) - 1/1/1998

Editor: American Society of Clinical Oncology

10.1200/jco.1998.16.4.1538 View at source

  • ISSN 0732183X
  • ISSN/ISBN 0732-183X

Desestabilización estructural de la adicción a oncogenes en cáncer de mama mediante el bloqueo de la sintasa de ácidos grasos

  • Colomer Bosch, Ramon (Investigador principal (IP))

Period: 01-01-2012 - 31-12-2014

  • iMarina

Cambios en el perfil inmunohistoquímico tras tratamiento neoadyuvante en pacientes con cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Miguel Martín Giménez (Director) Doctorando: Rebeca Mondéjar Solís

1/1/2016

  • iMarina

Características y evolución del cáncer de mama metástásico al diagnóstico: comparación con las recidivas del cáncer de mama inicialmente localizado

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: Antonio Jimeno Largo

1/1/2003

  • iMarina

Efectos de la inhibición de la síntesis de ácidos grasos en la eficacia de los tratamientos antineoplásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Alejandro Vázquez Martín

1/1/2007

  • iMarina

El fenotipo basal-her2 en el cáncer de mama: caracterización clínico-molecular e implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Javier Abel Menéndez Menéndez (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Begoña Martín Castillo

1/1/2016

  • iMarina

Estudio fase i/ii con dosis altas de mitoxantrone y ciclofosfamida sin soporte hematopoyético para el tratamiento de tumores de alto riesgo y metastásicos

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca (Director) Doctorando: José Luis Pérez Gracia

1/1/2004

  • iMarina

Importancia de la dosis de antraciclinas en el tratamiento adyuvante del cáncer de mama

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director)
  • Rafael Enríquez de Salamanca Lorente (Director) Doctorando: María Luz Amador Muñoz

1/1/2002

  • iMarina

Utilidad de la expresión de p53 en tumores de mama como factor pronóstico y predictor de la respuesta al tratamiento

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Cecilia Guzman Zapater

1/1/1996

  • iMarina

Ácidos grasos en la progresión del cáncer de mama: implicaciones terapéuticas

  • Colomer Bosch, Ramon (Autor o Coautor)
  • Ramón Colomer Bosch (Director) Doctorando: Javier Abel Menéndez Menéndez

1/1/2001

  • iMarina

Índice de Respuesta Inflamatoria Sistémica (IRIS): Factor Pronóstico en el Cáncer de Páncreas

  • Rebeca Mondéjar Solís (Director)
  • Ramón Colomer Bosch (Director) Doctorando: Pacheco Barcia, Vilma Emilia

28/1/2021

  • iMarina

This researcher has no patents or software licenses.

Last data update: 4/24/24 1:20 PM